Concepedia

Effect of Liraglutide Treatment on Prediabetes and Overweight or Obesity in Clozapine- or Olanzapine-Treated Patients With Schizophrenia Spectrum Disorder

Julie Rask Larsen, Louise Vedtofte, Mathilde S. L. Jakobsen, Hans Søe Riis Jespersen, Michelle Iris Jakobsen, Camilla Kara Svensson, Kamuran Koyuncu, Ole Schjerning, Peter Oturai, Jimmi Nielsen,

JAMA Psychiatry · 2017 · 210 citations · 22 references

DOIFull text

Open access

Abstract

clinicaltrials.gov Identifier: NCT01845259.

References

22

World Medical Association Declaration of Helsinki

JAMA · 2013 · 27.3K citations

, , +19

Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption‐II

John B. Saunders, Olaf Gjerløw Aasland, Thomas F. Babor et al. · Addiction · 1993 · 13K citations

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

Steven P. Marso, Gilbert H. Daniels, Kirstine Brown‐Frandsen et al. · New England Journal of Medicine · 2016 · 7K citations · Full text

Clozapine for the Treatment-Resistant Schizophrenic

John M. Kane · Archives of General Psychiatry · 1988 · 4.1K citations

A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management

F. Xavier Pi‐Sunyer, Arne Astrup, Ken Fujioka et al. · New England Journal of Medicine · 2015 · 2.4K citations · Full text